MEGAN HARMER: Open Payments
NPI 1083294706 · ST MICHAELS, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$201 in 11 payments from 7 companies in 2025. Trend: 2023 $560 · 2024 $222 · 2025 $201
Food & beverage: $201
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 2 | $37 |
| Novo Nordisk Inc | 2 | $36 |
| Exact Sciences Corporation | 2 | $36 |
| Amgen Inc. | 2 | $34 |
| Astellas Pharma US Inc | 1 | $24 |
| ABBVIE INC. | 1 | $20 |
| AstraZeneca Pharmaceuticals LP | 1 | $14 |
Products named: Veozah, MOUNJARO, Cologuard Collection Kit, QULIPTA, Ozempic, REPATHA, OTEZLA, Wegovy.
Industry payments across MD — which companies pay providers there.
